US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist
  • 0.006730
  • -0.000470-6.53%
15min DelayClose Oct 2 16:00 ET
209.38KMarket Cap0.02P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
101.21%225
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
32.64%-1.68M
74.30%-149.51K
Net income from continuing operations
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
0.35%-3.71M
-19.56%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-16.55%-3.72M
29.57%-479.71K
Operating gains losses
----
----
----
21,398.69%2.73M
--330.93K
----
----
----
93.47%-12.8K
----
Depreciation and amortization
--0
-18.65%32.86K
-8.62%39.46K
-18.37%162.06K
-18.60%38.49K
-18.09%39.99K
-20.16%40.39K
-16.67%43.19K
-10.14%198.53K
-7.23%47.29K
Other non cash items
94.84%-123.71K
-94.62%129.06K
152.17%11.45K
-92.41%54.81K
1,090.89%45.78K
-6,088.10%-2.4M
--2.4M
--4.54K
-2.48%722.24K
-94.35%3.84K
Change In working capital
223.26%60.89K
-69.27%74.12K
-84.99%20.79K
16.43%474.13K
-27.54%143.89K
-143.90%-49.4K
413.58%241.17K
181.75%138.47K
735.76%407.23K
1,106.71%198.58K
-Change in receivables
149.33%120.15K
-438.19%-57.49K
842.43%25.32K
-111.20%-13.84K
268.20%210.03K
-908.01%-243.56K
66.42%17K
-89.75%2.69K
1,286.44%123.6K
1,494.01%57.04K
-Change in payables and accrued expense
-96.49%10.69K
-45.74%61.66K
-103.34%-4.53K
72.05%487.97K
-146.73%-66.14K
269.79%304.69K
209.27%113.64K
491.81%135.78K
628.80%283.62K
1,005.33%141.54K
Cash from discontinued investing activities
Operating cash flow
101.21%225
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
32.64%-1.68M
74.30%-149.51K
Investing cash flow
Cash flow from continuing investing activities
94.67K
-19.03%20K
-1.2K
-2.09%24.7K
0
0
24.7K
0
-96.09%25.23K
25.74K
Net PPE purchase and sale
--114.67K
--0
---1.2K
--0
--0
--0
--0
--0
2,775.40%25.23K
--25.74K
Net investment purchase and sale
---20K
----
----
--24.7K
--0
--0
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--94.67K
-19.03%20K
---1.2K
-2.09%24.7K
--0
--0
--24.7K
--0
-96.09%25.23K
--25.74K
Financing cash flow
Cash flow from continuing financing activities
-91.60%1.26K
0
24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
19.98K
0
-84.13%389.86K
149.86K
Net issuance payments of debt
-91.60%1.26K
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
-84.13%389.86K
--149.86K
Cash from discontinued financing activities
Financing cash flow
-91.60%1.26K
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
-84.13%389.86K
--149.86K
Net cash flow
Beginning cash position
-22.21%37.14K
278.00%81.65K
10.37%129.7K
-91.52%117.52K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
-91.52%117.52K
78.30%1.39M
-95.15%96.28K
Current changes in cash
2,773.26%96.16K
-499.26%-104.4K
49.90%-48.05K
100.96%12.18K
227.88%85.55K
97.34%-3.6K
104.71%26.15K
84.02%-95.92K
-307.62%-1.26M
104.35%26.09K
Effect of exchange rate changes
---59.89K
----
----
--0
--0
--0
----
----
---4.85K
---4.85K
End cash Position
66.26%73.41K
-22.21%37.14K
278.00%81.65K
10.37%129.7K
10.37%129.7K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
-91.52%117.52K
-91.52%117.52K
Free cash flow
101.21%225
-571.26%-124.4K
23.85%-73.04K
93.31%-112.52K
113.62%20.52K
95.05%-18.59K
94.83%-18.53K
87.96%-95.92K
32.60%-1.68M
74.11%-150.65K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 101.21%225-571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K32.64%-1.68M74.30%-149.51K
Net income from continuing operations 15.55%-130.63K87.60%-325.46K50.09%-178.52K0.35%-3.71M-19.56%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-16.55%-3.72M29.57%-479.71K
Operating gains losses ------------21,398.69%2.73M--330.93K------------93.47%-12.8K----
Depreciation and amortization --0-18.65%32.86K-8.62%39.46K-18.37%162.06K-18.60%38.49K-18.09%39.99K-20.16%40.39K-16.67%43.19K-10.14%198.53K-7.23%47.29K
Other non cash items 94.84%-123.71K-94.62%129.06K152.17%11.45K-92.41%54.81K1,090.89%45.78K-6,088.10%-2.4M--2.4M--4.54K-2.48%722.24K-94.35%3.84K
Change In working capital 223.26%60.89K-69.27%74.12K-84.99%20.79K16.43%474.13K-27.54%143.89K-143.90%-49.4K413.58%241.17K181.75%138.47K735.76%407.23K1,106.71%198.58K
-Change in receivables 149.33%120.15K-438.19%-57.49K842.43%25.32K-111.20%-13.84K268.20%210.03K-908.01%-243.56K66.42%17K-89.75%2.69K1,286.44%123.6K1,494.01%57.04K
-Change in payables and accrued expense -96.49%10.69K-45.74%61.66K-103.34%-4.53K72.05%487.97K-146.73%-66.14K269.79%304.69K209.27%113.64K491.81%135.78K628.80%283.62K1,005.33%141.54K
Cash from discontinued investing activities
Operating cash flow 101.21%225-571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K32.64%-1.68M74.30%-149.51K
Investing cash flow
Cash flow from continuing investing activities 94.67K-19.03%20K-1.2K-2.09%24.7K0024.7K0-96.09%25.23K25.74K
Net PPE purchase and sale --114.67K--0---1.2K--0--0--0--0--02,775.40%25.23K--25.74K
Net investment purchase and sale ---20K----------24.7K--0--0----------0--0
Cash from discontinued investing activities
Investing cash flow --94.67K-19.03%20K---1.2K-2.09%24.7K--0--0--24.7K--0-96.09%25.23K--25.74K
Financing cash flow
Cash flow from continuing financing activities -91.60%1.26K024.99K-74.35%100K-56.61%65.03K-93.75%14.99K19.98K0-84.13%389.86K149.86K
Net issuance payments of debt -91.60%1.26K--0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0-84.13%389.86K--149.86K
Cash from discontinued financing activities
Financing cash flow -91.60%1.26K--0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0-84.13%389.86K--149.86K
Net cash flow
Beginning cash position -22.21%37.14K278.00%81.65K10.37%129.7K-91.52%117.52K-54.14%44.15K-79.39%47.75K-97.25%21.6K-91.52%117.52K78.30%1.39M-95.15%96.28K
Current changes in cash 2,773.26%96.16K-499.26%-104.4K49.90%-48.05K100.96%12.18K227.88%85.55K97.34%-3.6K104.71%26.15K84.02%-95.92K-307.62%-1.26M104.35%26.09K
Effect of exchange rate changes ---59.89K----------0--0--0-----------4.85K---4.85K
End cash Position 66.26%73.41K-22.21%37.14K278.00%81.65K10.37%129.7K10.37%129.7K-54.14%44.15K-79.39%47.75K-97.25%21.6K-91.52%117.52K-91.52%117.52K
Free cash flow 101.21%225-571.26%-124.4K23.85%-73.04K93.31%-112.52K113.62%20.52K95.05%-18.59K94.83%-18.53K87.96%-95.92K32.60%-1.68M74.11%-150.65K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data